Might be getting ahead of ourself yet this is worth noting:
"Prior to joining Imugene, he served as Chief Financial Officer and Company
Secretary at Clinuvel Pharmaceuticals Ltd from 2005 to 2024, where he played a pivotal
role in the company’s transformation from a small biotech start-up to a cash generating,
profitable, multinational, ASX-listed organisation."
CUV has really strong fundamentals, revenue generation, and is about to breakout and do very well. (Ignore the shorters, they are about to be burned.)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |